# L-Carnitine as an Adjuvant Treatment in Acute Phosphide Poisoning (LC)

> **NCT03953248** · EARLY_PHASE1 · COMPLETED · sponsor: **Heba Allah Ali Abd El-Halim Mabrouk** · enrollment: 50 (actual)

## Conditions studied

- Toxicity

## Interventions

- **DRUG:** L-Carnitine

## Key facts

- **NCT ID:** NCT03953248
- **Lead sponsor:** Heba Allah Ali Abd El-Halim Mabrouk
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953248, "L-Carnitine as an Adjuvant Treatment in Acute Phosphide Poisoning (LC)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03953248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*